Literature DB >> 24648818

Factors affecting the development of adverse drug reactions (Review article).

Muaed Jamal Alomar1.   

Abstract

OBJECTIVES: To discuss the effect of certain factors on the occurrence of Adverse Drug Reactions (ADRs). DATA SOURCES: A systematic review of the literature in the period between 1991 and 2012 was made based on PubMed, the Cochrane database of systematic reviews, EMBASE and IDIS. Key words used were: medication error, adverse drug reaction, iatrogenic disease factors, ambulatory care, primary health care, side effects and treatment hazards.
SUMMARY: Many factors play a crucial role in the occurrence of ADRs, some of these are patient related, drug related or socially related factors. Age for instance has a very critical impact on the occurrence of ADRs, both very young and very old patients are more vulnerable to these reactions than other age groups. Alcohol intake also has a crucial impact on ADRs. Other factors are gender, race, pregnancy, breast feeding, kidney problems, liver function, drug dose and frequency and many other factors. The effect of these factors on ADRs is well documented in the medical literature. Taking these factors into consideration during medical evaluation enables medical practitioners to choose the best drug regimen.
CONCLUSION: Many factors affect the occurrence of ADRs. Some of these factors can be changed like smoking or alcohol intake others cannot be changed like age, presence of other diseases or genetic factors. Understanding the different effects of these factors on ADRs enables healthcare professionals to choose the most appropriate medication for that particular patient. It also helps the healthcare professionals to give the best advice to patients. Pharmacogenomics is the most recent science which emphasizes the genetic predisposition of ADRs. This innovative science provides a new perspective in dealing with the decision making process of drug selection.

Entities:  

Keywords:  ADRS; Affecting; Drugs; Factors; Reaction

Year:  2013        PMID: 24648818      PMCID: PMC3950535          DOI: 10.1016/j.jsps.2013.02.003

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  122 in total

1.  Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.

Authors:  R Yuan; J Venitz
Journal:  Int J Clin Pharmacol Ther       Date:  2000-05       Impact factor: 1.366

Review 2.  Gender-based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy.

Authors:  M H Ensom
Journal:  Pharmacotherapy       Date:  2000-05       Impact factor: 4.705

Review 3.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

4.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

Review 5.  Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

Authors:  Lisa M Ebert; Patrick Schaerli; Bernhard Moser
Journal:  Mol Immunol       Date:  2004-11-23       Impact factor: 4.407

6.  Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol-O-methyltransferase inhibitors in Parkinson's disease patients.

Authors:  Marco Ferrari; Emilia Martignoni; Fabio Blandini; Giulio Riboldazzi; Giorgio Bono; Franca Marino; Marco Cosentino
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

7.  Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis.

Authors:  Maria de Fátima Silva de Lima; Heloísa Ramos Lacerda de Melo
Journal:  Cad Saude Publica       Date:  2012-04       Impact factor: 1.632

8.  Adverse drug reaction risk factors in older outpatients.

Authors:  Emily R Hajjar; Joseph T Hanlon; Margaret B Artz; Catherine I Lindblad; Carl F Pieper; Richard J Sloane; Christine M Ruby; Kenneth E Schmader
Journal:  Am J Geriatr Pharmacother       Date:  2003-12

9.  Pharmacoepidemiology of potential alcohol-prescription drug interactions among primary care patients with alcohol-use disorders.

Authors:  Richard L Brown; Alan R Dimond; Darrell Hulisz; Laura A Saunders; James A Bobula
Journal:  J Am Pharm Assoc (2003)       Date:  2007 Mar-Apr

10.  A survey on polypharmacy and use of inappropriate medications.

Authors:  Sujit Rambhade; Anup Chakarborty; Anand Shrivastava; Umesh K Patil; Ashish Rambhade
Journal:  Toxicol Int       Date:  2012-01
View more
  94 in total

1.  Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Authors:  Hyejeong Hong; Kelly E Dooley; Laura E Starbird; Howard W Francis; Jason E Farley
Journal:  Arch Toxicol       Date:  2019-04-08       Impact factor: 5.153

2.  Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids.

Authors:  Marin Roman; Diana Larisa Roman; Vasile Ostafe; Alecu Ciorsac; Adriana Isvoran
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

3.  Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.

Authors:  Saibal Das; Sapan K Behera; Alphienes S Xavier; Srinivas Velupula; Steven A Dkhar; Sandhiya Selvarajan
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

Review 4.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

5.  Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats.

Authors:  Lujing Wang; Wenji Li; David Cheng; Yue Guo; Renyi Wu; Ran Yin; Shanyi Li; Hsiao-Chen Kuo; Rasika Hudlikar; Hilly Yang; Brian Buckley; Ah-Ng Kong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-04       Impact factor: 2.745

6.  Pharmacovigilance in developing countries (part I): importance and challenges.

Authors:  Shaimaa Elshafie; Iman Zaghloul; Anne Marie Roberti
Journal:  Int J Clin Pharm       Date:  2018-08

Review 7.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

8.  Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.

Authors:  George Tsey Sabblah; Delese Mimi Darko; Hudu Mogtari; Linda Härmark; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

Review 9.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

10.  Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®.

Authors:  Jitka Pokladnikova; Ronald H B Meyboom; Ricarda Meincke; David Niedrig; Stefan Russmann
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.